DNA Script (South San Francisco, California) has launched its next-generation SYNTAX system, which it describes as “the world’s first DNA printer powered by enzymatic DNA Synthesis (EDS).” The company recently announced that the SYNTAX system now offers support for q/dPCR assays, supporting same-day results. DNA Script describes the offering as the first to offer a…

DNA Script announced today that it raised $165 million in a Series C financing round, bringing its total capital raised to $280 million. South San Francisco-based DNA Script earmarked the funds raised to accelerate expansion and commercialization for the company’s Syntax benchtop nucleic acid printer and to broaden its portfolio of products powered by enzymatic…

DNA Script announced the commercial launch of its Syntax platform with the Syntax system, a benchtop nucleic acid printer. South San Francisco, Calif.-based DNA Script designed its Syntax system, a fully integrated, automated printer powered by enzymatic DNA synthesis (EDS) technology, to synthesize 96 DNA oligos in parallel, comprised of up to 60 nucleotides in…